A phase I/II clinical trial of preoperative short‐course carbon‐ion radiotherapy for patients with squamous cell carcinoma of the esophagus

Carbon‐ion radiotherapy (CIR) has been under development. We report the results of a phase I/II clinical trial of preoperative CIR for esophageal squamous cell carcinoma (ESCC).

[1]  K. Muro,et al.  Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). , 2011, International journal of radiation oncology, biology, physics.

[2]  H. Matsubara,et al.  The significance of lymph node status as a prognostic factor for esophageal cancer , 2011, Surgery Today.

[3]  Y. Tachimori,et al.  Comprehensive Registry of Esophageal Cancer in Japan, 2003 , 2011, Esophagus.

[4]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[5]  J. V. van Sandick,et al.  Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer , 2010, The British journal of surgery.

[6]  H. Ishwaran,et al.  Cancer of the esophagus and esophagogastric junction , 2010, Cancer.

[7]  Tohru Okada,et al.  Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). , 2010, Journal of radiation research.

[8]  Y. Doki,et al.  Pre- and post-therapy nodal status equally affects survival of patients with oesophageal squamous cell carcinoma receiving preoperative chemoradiation. , 2010, Oncology reports.

[9]  Hong Zhu,et al.  Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. , 2009, World journal of gastroenterology.

[10]  H. Matsubara,et al.  Perioperative management for the prevention of postoperative pneumonia with esophageal surgery. , 2009, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[11]  Ewout W. Steyerberg,et al.  Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Review of Meta-Analyses , 2009, World Journal of Surgery.

[12]  G. Williams,et al.  The assessment of prognosis of surgically resected oesophageal cancer is dependent on the number of lymph nodes examined pathologically , 2009, Histopathology.

[13]  H. Matsubara,et al.  Clinical and Pathologic Evaluation of the Effectiveness of Neoadjuvant Chemoradiation Therapy in Advanced Esophageal Cancer Patients , 2009, World Journal of Surgery.

[14]  E. Steyerberg,et al.  Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS) , 2008, BMC surgery.

[15]  Matthew Z. Wilson,et al.  Prognostic significance of lymph node metastases and ratio in esophageal cancer. , 2008, The Journal of surgical research.

[16]  C. Divino,et al.  Prognostic significance of the number of lymph node metastases in esophageal cancer. , 2008, Journal of the American College of Surgeons.

[17]  H. Tsujii,et al.  Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. , 2007, International journal of radiation oncology, biology, physics.

[18]  Tatsuaki Kanai,et al.  Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  T. Nakano,et al.  Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. , 2006, International journal of radiation oncology, biology, physics.

[20]  V. Gebski,et al.  Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. , 2005, The Lancet. Oncology.

[21]  P. Devitt,et al.  Postoperative mortality following oesophagectomy and problems in reporting its rate , 2004, The British journal of surgery.

[22]  T. Obata,et al.  Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. , 2004, International journal of radiation oncology, biology, physics.

[23]  A. Venturi,et al.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis , 2004, Gut.

[24]  S Minohara,et al.  Respiratory gated irradiation system for heavy-ion radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[25]  M. Endo,et al.  Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. , 1999, The Annals of thoracic surgery.

[26]  S Minohara,et al.  Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. , 1999, International journal of radiation oncology, biology, physics.

[27]  Shinichi Minohara,et al.  HIPLAN-A HEAVY ION TREATMENT PLANNING SYSTEM AT HIMAC , 1996 .

[28]  P. Puttisak,et al.  A prospective study of combined therapy in esophageal cancer. , 1994, Hepato-gastroenterology.

[29]  M. Hassel,et al.  A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus , 1994, Cancer.

[30]  Japanese Society for Esophageal Diseases.  Guide lines for the clinical and pathologic studies for carcinoma of the esophagus , 2006, The Japanese journal of surgery.

[31]  T Kanai,et al.  Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy. , 1997, Radiation research.

[32]  K. Isono,et al.  Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. , 1991, Oncology.